A halo naevus (US spelling, nevus) is an otherwise normal mole with a white ring, or halo, around it. The central dark brown naevus fades from dark brown to light brown to pink, eventually disappearing completely.
Halo naevus is also known as:
Halo melanocytic naevus
Halo mole
Regressing naevus
Sutton naevus
Leukoderma acquisitum centrifugum.
Halo naevi
Halo naevus
Halo naevus
Who gets halo naevi?
Halo naevi (US plural, nevi) are not uncommon, with an estimated prevalence of 1% of the white-skinned population. They are usually seen in healthy children or young adults of either sex. They can occur at an older age too.
Halos can be seen as part of a more generalisedpigment loss, vitiligo, and halo naevi may also be associated with another autoimmune disease.
Why halo naevi develop is not fully understood. They are currently classified as autoimmune in origin.
The onset of a halo naevus may be triggered by sunburn or local trauma, which causes the mole to be recognised by the immune system as foreign, resulting in an attack by circulating antibodies and CD8+ T lymphocytes. The reaction also affects the normal skin around the mole, which also has pigment cells in it, causing depigmentation.
Development of halo naevi has also been associated with psychosocial stress.
What are the clinical features of halo naevi?
A solitary halo naevus or multiple halo naevi are most often found on the trunk. They are less common on the head and are rare on the limbs. The affected naevi are dermal naevi that are congenital or have arisen during childhood. Halo naevi may follow the Koebner phenomenon, arising within a mole that has been injured in some way.
The white halo is usually about 0.5–1.0 cm wide and is symmetrical (round or oval in shape). The halos develop at intervals round one or several moles, but not around all of them.
There are four stages of a halo naevus. It may take several years to complete the cycle. Multiple halo naevi can be at different stages.
Stage 1: A rim of pale skin surrounds a mole
Stage 2: The mole may become pinker or less pigmented, and fades away
Stage 3: A circular or oval area of depigmentation persists
Stage 4: The affected skin gradually returns to its normal colour
Halo naevus is a clinical diagnosis. Dermoscopy may be used to evaluate the structure and colour of the naevus.
A full skin examination should be performed (especially in adults), as rarely, halo naevi can be triggered by the presence of a melanoma elsewhere.
Occasionally, if it has atypical features such as irregularity in structure or colour, excision of a solitary halo naevus is recommended to make sure it is benign.Histology reveals a band-like lymphohistiocyticinfiltrate in the dermis under the naevus.
Dermoscopy of halo naevi
Halo naevus dermoscopy
Halo naevus dermoscopy
Halo naevus dermoscopy
What is the differential diagnosis for halo naevus?
The differential diagnosis of halo naevus includes:
Where there is doubt about the diagnosis, the whole naevus should be excised for histopathological examination. Partial biopsy could be misleading.
Concerning lesions with depigmentation — all excised for histopathology
Recurrent naevus in scar (dermoscopy view)
Atypical naevus with depigmentation
Melanoma with depigmentation
What is the treatment of halo naevus?
Apart from an explanation, no treatment is normally required for a typical halo naevus.
The white skin of a halo naevus will burn particularly easily in the sun because it is missing protective melanin pigment. Cover up or apply sunscreen during summer to prevent sunburn.
Surgery is not usually necessary but may be recommended if there are atypical features such as irregularity in the structure of the naevus.
References
Weyant GW, Chung CG, Helm KF. Halo nevus: review of the literature and clinicopathologic findings. Int J Dermatol. 2015 Oct;54(10):e433-5. doi: 10.1111/ijd.12843. Epub 2015 Jul 3. Review. PubMed PMID: 26146814. PubMed.
Zhou H, Wu LC, Chen MK, Liao QM, Mao RX, Han JD. Factors Associated with Development of Vitiligo in Patients with Halo Nevus. Chin Med J (Engl). 2017 Nov 20;130(22):2703-2708. doi: 10.4103/0366-6999.218011. PubMed PMID: 29133759; PubMed Central PMCID: PMC5695056. PubMed Central.